Home Antibody All anti-NDUFB9 antibodies
Also for NDUFB9 (NM_005005)
|LYRM3 antibody was raised against a 17 amino acid peptide near the carboxy terminus of human LYRM3.|
|Human, Mouse, Rat
|WB, IHC, IF
||WB: 1 - 2 ug/ml, IHC: 5 ug/ml, IF: 20 ug/ml
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa (NDUFB9), transcript variant 1|
|B22; CI-B22; LYRM3; UQOR22|
|LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of LYRM3 in human liver tissue lysate with LYRM3 antibody at (A) 1 and (B) 2 ug/mL.
Immunohistochemistry of LYRM3 in rat liver tissue with LYRM3 antibody at 5 ug/mL.
Immunofluorescence of LYRM3 in rat liver tissue with LYRM3 antibody at 20 ug/mL.